G9a Chemiluminescent Assay Kit

Catalog #
52001L
$750 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The G9a Chemiluminescent Assay Kit is designed to measure G9a activity for screening and profiling applications. This kit comes in a convenient format, with a plate precoated with histone H3 peptide substrate, recombinant human G9a enzyme (amino acids 785-1210), high specific antibody against the methylated lysine residue of Histone H3, secondary HRP-labeled antibody, S-adenosylmethionine and Methyltransferase Assay Buffer for 100 enzyme reactions.

Figure 1: G9a Chemiluminescent Assay Kit workflow diagram. First, S-adenosylmethionine is incubated with the assay buffer, G9a enzyme, and the inhibitor of choice for one hour in a histone-precoated plate. This is followed by the addition of a primary antibody against Lys(Me). Addition of a chemiluminescent HRP substrate provides a luminescence signal, which directly correlates with the activity of G9a.

Need us to run inhibitor screens or profile your compounds against G9a? Check out our Methyltransferase Screening Services

This product has been cited 1 time.

Synonyms
G9a, EHMT2, KMT1C, euchromatic histone-lysine N-methyltransferase 2
Product Info
Storage and Usage
Citations1
Assay Kit Format
Chemiluminescent
Materials Required But Not Supplied
  • TBST Buffer (1x TBS, containing 0.05% Tween-20), pH 8
  • Luminometer or plate reader capable of reading chemiluminescence
  • Adjustable micropipettor and sterile tips
  • Orbital shaker
Format
Catalog # Name Amount Storage
51001 G9a (EHMT2), GST-Tag (Sf9-derived)* 8 µg -80°C
52120 20 µM S-adenosylmethionine 250 µl -80°C
52140E Primary Antibody 5 12.5 µl -80°C
52130H Secondary HRP-Labeled Antibody 1 10 µl -80°C
52160 4x HMT Assay Buffer 1 3 ml -20°C
52100 Blocking Buffer 4 50 ml +4°C
  0.5 M DTT 200 µl -20°C
  HRP Chemiluminescence Substrate (2 components) 6 ml each +4°C
  96-well module plate (pre-coated with Histone Substrate)** 1 plate +4°C

*The concentration of the protein is lot-specific and will be indicated on the tube.
**Custom coated plates (example, with a lower concentration of Histone Substrate) are available upon request.

UniProt #
Q96KQ7
Background

G9a, also known as euchromatic histone-lysine N-methyltransferase 2 or EHMT2, belongs to the histone methyltransferase enzyme family. It is involved in mono- and di-methylation of histone H3, at lysine 9 and lysine 27, which control epigenetic regulation of pluripotency during embryogenesis, by depositing H3K9me2 in the promoters of genes like OCT4 (octamer-binding transcription factor 4). It is also involved in neuropathic pain, by regulating a large number of genes in the dorsal root ganglia. G9a has been implicated in cancer cell growth, having a key role in self-renewal of cancer stem cells (CSCs). The presence of CSC populations leads to cancer resurfacing after treatment and they tend to be resistant to typical cancer treatments. The use of inhibitors targeting G9a can result in toxicity, such as in the case of UNC0642 or BIX-01294. The development of newer context-specific inhibitors will provide new therapeutic avenues in cancer therapy.

References

Dillon S. C., et al., 2005 Genome Biology 6:227.
Haebe J., et al., 2021 Oncogenesis 10: 76.